Pando Bioscience (YC W23)
Private Company
Create Gen-AI Designed Enzymes for Pharmaceutical Innovation
Biotechnology Research
Watertown, Massachusetts
2-10 employees
Founded 2023
About Pando Bioscience (YC W23)
Pando Bioscience leverages generative AI to revolutionize synthetic biology, offering an advanced platform for engineering high-performance enzymes. The company provides custom enzyme design services and proprietary polymerase products to pharmaceutical, diagnostics, and biotech organizations. Its technology enables clients to accelerate development, enhance productivity, and reduce costs for applications in manufacturing and molecular biology.
Company Classification
Customer Types
B2B
Business Models
ProductsServices
Product & Service Types
AI-powered enzyme design platformCustom enzyme engineering servicesEngineered enzymes and polymerases
Funding
Total Funding
$500.0K
No. of Funding Rounds
1
Customers
| Customer | Success Story | Source |
|---|---|---|
| Developed novel polymerase for library preparation for NGS with unique sequence identification | ||
| Used Pando's enzyme engineering to improve enzymatic step in small molecule synthesis |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos